The molecular basis of asbestos induced lung injury.
Kamp
D W
DW
Department of Medicine, Pulmonary & Critical Care Medicine, Veterans Affairs Chicago Health Care System (Lakeside Division) and Northwestern University Medical School, Chicago, Illinois 60611, USA.
Weitzman
S A
SA
D017209:Apoptosis; D001194:Asbestos / Q000009:adverse effects*; D001195:Asbestosis / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D002462:Cell Membrane / Q000378:metabolism / Q000473:pathology; D016207:Cytokines / Q000378:metabolism; D004249:DNA Damage; D005609:Free Radicals / Q000378:metabolism; D016147:Genes, Tumor Suppressor; D006801:Humans; D015227:Lipid Peroxidation; D008168:Lung / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D008954:Models, Biological; D011658:Pulmonary Fibrosis / Q000209:etiology* / Q000378:metabolism / Q000473:pathology; D017382:Reactive Oxygen Species / Q000378:metabolism; D015290:Second Messenger Systems; D015533:Transcriptional Activation
D016207:Cytokines; D005609:Free Radicals; D017382:Reactive Oxygen Species; D001194:Asbestos